The prognosis of patients with basal and squamous cell carcinoma of the skin

International Journal of Dermatology

Volumn 37, Issue 9, 1998, Pages 656-658

  Czarnecki, D ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BASAL CELL CARCINOMA; CANCER RISK; HUMAN; METASTASIS; MULTIPLE CANCER; NOTE; PROGNOSIS; RECURRENT CANCER; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; MELANOMA; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; SKIN NEOPLASMS;

EID: 0031754520     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00559.x     Document Type: Note

References (33)

1. Balch, CM, Soong, S, Shaw, H, etal. An analysis of prognostic factors in 4000 patients with cutaneous melanoma. In: Balch, CM Milton, G, eds. Cutaneous Melanoma. Philadelphia: Lippincott.: 321 1985.
2. Weedon, D & Wall, D. Metastatic basal cell carcinoma. Med J Aust. ; 1975, 133, 177 179.
3. Paver, K, Poyzer, K, Burry, N, etal. The incidence of basal cell carcinomas and their metastases in Australia and New Zealand. Aust J Dermatol. ; 1973, 14, 53 55.
4. Snow, SN, Sahl, W, Lo, JS, etal. Metastatic basal cell carcinoma. Cancer. ; 1994, 73, 328 335.
5. Domasrus, H & Stevens, PJ. Metastatic basal cell carcinoma. J Am Acad Dermatol. ; 1984, 10, 643 660.
6. Czarnecki, D, Staples, M, Mar, A, etal. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. ; 1994, 189, 52 54.
7. MacDonald, EJ & Bubendorf, E. Some epidemiological aspects of skin cancer. In: MacDonald, EJ, ed. Tumours of the Skin. Chicago: Year Book Publishers., 1964 : 23 65.
8. Chuang, TY, Popescu, NA, Su, WP. Squamous cell carcinoma. Arch Dermatol. ; 1990, 126, 185 188.
9. Moller, R, Reyman, F, How-Jensen, K. Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol. ; 1979, 115, 701 705.
10. Breyninger, H, Black, B, Ressinger, G. Microstaging of squamous cell carcinoma. Am J Pathol. ; 1990, 94, 624 627.
11. Rowe, DE, Carroll, RJ, Day, CL. Prognostic factors for local recurrence, metastases and survival rates in squamous cell carcinoma of the skin, ear and lip. J Am Acad Dermatol. ; 1992, 26, 976 990.
12. Weinstock, MA, Morris, SB, Lederman, JS, etal. Effects of BANS location on the prognosis of clinical Stage 1 melanoma. New data and metanalysis. Br J Dermatol. ; 1988, 119, 559 565.
13. Friedman, HI, Cooper, PM, Wanebo, HJ. Prognostic and therapeutic use of microstaging on cutaneous squamous cell carcinoma of the trunk and extremities. Cancer. ; 1985, 56, 1099 1101.
14. Weinstock, MA, Bogaars, MA, Ashley, M, etal. Nonmelanoma skin cancer mortality. Arch Dermatol. ; 1991, 127, 194 197.
15. Gordon, H & Silverstone, H. Deaths from skin cancer in Queensland, Australia. In: Urbach F. The Biological Effects of Ultraviolet Radiation. Oxford: Pergamon Press.: 625 1969.
16. Czarnecki, D, Mar, A, Staples, M, etal. The development of non-melanocytic skin cancers in people with a history of skin cancer. Dermatology. ; 1994, 189, 364 367.
17. Robinson, JK. Risk of developing another basal cell carcinoma; a 5 year prospective study. Cancer. ; 1987, 60, 118 120.
18. Karagas, MR, Stukel, SA, Greenberg, ER, etal. Risk of subsequent basal cell and squamous cell carcinoma of the skin among patients with prior skin cancer. JAMA. ; 1992, 267, 3305 3310.
19. Epstein, E. Value of follow-up after treatment of basal cell carcinoma Arch Dermatol.; 1973, 108, 798 800.
20. Rowe, DE, Carroll, RJ, Day, CL. Long term recurrence rates in previously untreated (primary) basal cell carcinoma; implications for patient follow-up. JDermatol Surg Oncol. ; 1989, 15, 315 328.
21. Czarnecki, D, Staples, M, Mar, A, etal. Recurrent nonmelanoma skin cancer in southern Australia. Int J Dermatol. ; 1996, 35, 410 412.
22. Goepert, H, Dichtel, WJ, Medina, JE, etal. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. ; 1984, 148, 542 547.
23. Karajalanainen, S & Hakulein, J. Survival and prognostic factors in patients with skin melanoma. A regression model analysis based upon nationwide cancer registry data. Cancer. ; 1988, 62, 2271 2280.
24. Dzubin, LM, Rigel, DS, Robins, P. Risk factors for local recurrences of primary squamous cell carcinoma. Arch Dermatol. ; 1982, 126, 900 902.
25. Dublin, N & Kopf, AW. Multivariate risk score for recurrent cutaneous basal cell carcinomas. Arch Dermatol. ; 1983, 119, 393 397.
26. Ashby, MA, Smith, J, Ainslie, J, etal. Treatment of nonmelanoma skin cancer in a large Australian centre. Cancer. ; 1989, 63, 1863 1871.
27. Czarnecki, D, O'Brien, T, Meehan, C. Nonmelanoma skin cancer: numbers of cancers and their distribution in outpatients. Int J Dermatol. ; 1994, 33, 416 417.
28. Sober, AJ, Day, CL, Fitzpatrick, TB, etal. Early death from clinical stage 1 melanoma. J Invest Dermatol. ; 1983, 80, 50s 52s.
29. Slingluff, CL, Volimer, RT, Reintgen, DS, etal. Lethal "thin" malignant melanoma: identifying patients at risk. Ann Surg. ; 1988, 208, 150 161.
30. Schmoekel, C & Braun-Falco, O. Prognostic index in melanoma. Arch Dermatol. ; 1978, 114, 871 873.
31. Kopf, A, Gross, D, Rogers, G, etal. Prognostic index for malignant melanoma. Cancer. ; 1987, 59, 1236 1241.
32. Giles, G, Marks, R, Foley, P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J. ; 1988, 296, 13 18.
33. Kricker, A, English, D, Randell, P, etal. Skin cancer in Geraldton, Western Australia; a survey on incidence and prevalence. Med J Aust. ; 1990, 152, 399 407.